We are live on ! Find out more
ARCT icon

Arcturus Therapeutics
ARCT

113 hedge funds and large institutions have $379M invested in Arcturus Therapeutics in 2022 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 38 increasing their positions, 36 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

123% more call options, than puts

Call options by funds: $6.67M | Put options by funds: $2.99M

16% more capital invested

Capital invested by funds: $328M → $379M (+$51.2M)

2.06% more ownership

Funds ownership: 83.4% → 85.46% (+2.1%)

6% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 36

5% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 20

3% less funds holding

Funds holding: 116 → 113 (-3)

Holders
113
Holders Change
-3
Holders Change %
-2.59%
% of All Funds
1.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
38
Reduced
36
Closed
20
Calls
$6.67M
Puts
$2.99M
Net Calls
+$3.68M
Net Calls Change
+$1.69M

Top Buyers

1
Federated Hermes
Federated Hermes
Pennsylvania
+$11.7M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$11.6M
3
Bank of America
Bank of America
North Carolina
+$10.1M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$2.79M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.98M

Top Sellers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$9.64M
2
State Street
State Street
Massachusetts
-$8.24M
3
AIM
ARK Investment Management
Florida
-$2.95M
4
WP
Woodline Partners
California
-$2.18M
5
IHAM
Integral Health Asset Management
New York
-$1.93M
Name Holding Trade Value Shares
Change 		Change in
Stake
BAM
76
Byrne Asset Management
New Jersey
$110K +$34.8K +1,995 +44%
Royal Bank of Canada
77
Royal Bank of Canada
Ontario, Canada
$101K +$33.7K +1,934 +48%
Zurich Cantonal Bank
78
Zurich Cantonal Bank
Switzerland
$98.2K +$15.4K +882 +18%
PMEF
79
Point72 Middle East FZE
United Arab Emirates
$79.3K +$81.5K +4,673 New
Simplex Trading
80
Simplex Trading
Illinois
$66K +$53.6K +3,074 +353%
AB
81
Amalgamated Bank
New York
$62K – – –
Daiwa Securities Group
82
Daiwa Securities Group
Japan
$56K -$26.9K -1,540 -32%
QT
83
Quantbot Technologies
New York
$38.9K +$40K +2,296 New
Canada Life
84
Canada Life
Manitoba, Canada
$35K +$4.31K +247 +14%
Osaic Holdings
85
Osaic Holdings
Arizona
$33K -$5.79K -332 -14%
Allspring Global Investments
86
Allspring Global Investments
North Carolina
$31K +$11.7K +673 +58%
AIP
87
Ameritas Investment Partners
Nebraska
$30.9K – – –
NFSG
88
Newbridge Financial Services Group
Florida
$25.4K -$17.4K -1,000 -40%
MLICM
89
Metropolitan Life Insurance Company (MetLife)
New York
$23.6K – – –
US Bancorp
90
US Bancorp
Minnesota
$21.4K +$8.94K +513 +69%
IUHSA
91
Itau Unibanco Holding S.A.
Brazil
$19K -$8.8K -505 -31%
TRCT
92
Tower Research Capital (TRC)
New York
$16K -$48.6K -2,790 -75%
BAM
93
Belpointe Asset Management
Nevada
$12.6K +$13K +743 New
DFCM
94
Dark Forest Capital Management
Puerto Rico
$10.5K +$10.8K +620 New
CG
95
Cutler Group
California
$10K -$3.49K -200 -25%
Fifth Third Bancorp
96
Fifth Third Bancorp
Ohio
$8.48K – – –
Dimensional Fund Advisors
97
Dimensional Fund Advisors
Texas
$5.14K +$2.79M +159,743 +112%
CUAMC
98
China Universal Asset Management Company
China
$4.56K +$349 +20 +8%
EWM
99
Endurance Wealth Management
Rhode Island
$3K – – –
Nisa Investment Advisors
100
Nisa Investment Advisors
Missouri
$3K – – –
2 3
4
5 6

ARCT Hedge Fund Activity: Q4 2022 in Review

113 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Arcturus Therapeutics (ARCT) for Q4 2022, worth a combined $379M — up 16% from $328M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of ARCT and 19 opened new positions — a net loss of 1 holder — while 36 trimmed existing stakes and 38 added.

The largest buyer was Federated Hermes, adding an estimated $11.7M. The largest seller was Point72 Asset Management, cutting an estimated $9.64M.

  • 113 institutional investors held Arcturus Therapeutics (ARCT) as of Q4 2022, down from 116 in Q3 2022.
  • Funds reported $379M of Arcturus Therapeutics stock for Q4 2022, up 16% quarter-over-quarter.
  • 19 funds opened new Arcturus Therapeutics positions in Q4 2022 and 20 closed out, a net change of -1 holder.
  • The largest Arcturus Therapeutics buyer in Q4 2022 was Federated Hermes, an estimated $11.7M added.
  • The largest Arcturus Therapeutics seller in Q4 2022 was Point72 Asset Management, an estimated $9.64M sold.

Based on aggregated 13F filings for Q4 2022.